Prediction of Clinical Irrelevance of PK Differences in Atorvastatin Using PK/PD Models Derived From Literature‐Based Meta‐Analyses

By  

CLINICAL PHARMACOLOGY & THERAPEUTICS, Vol. 96, Iss. 1, 2014-07 ,pp. : 101-109

John Wiley & Sons Inc

Access to resources Recommend Favorite

Lipid altering-efficacy of ezetimibe co-administered with simvastatin compared with rosuvastatin: a meta-analysis of pooled data from 14 clinical trials

By Catapano Alberico   Brady William E.   King Thomas R.   Palmisano Joanne  

Current Medical Research and Opinion, Vol. 21, Iss. 7, 2005-07 ,pp. : 1123-1130

Informa Healthcare

Access to resources Recommend Favorite

P010: The global prevalence of chronic HBV infection: a systematic review and meta‐analyses on 48 years of published data

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 24-24

John Wiley & Sons Inc

Access to resources Recommend Favorite

What have we learnt from “real world” data, observational studies and meta‐analyses

By  

DIABETES OBESITY & METABOLISM (ELECTRONIC), Vol. 20, Iss. S1, 2018-02 ,pp. : 47-58

John Wiley & Sons Inc

Access to resources Recommend Favorite

The validation of surrogate endpoints in meta-analyses of randomized experiments

By Buyse M.  

Biostatistics, Vol. 1, Iss. 1, 2000-03 ,pp. : 49-67

Oxford University Press

Access to resources Recommend Favorite